EQRx, Inc. (EQRX) Social Stream



EQRx, Inc. (EQRX): $2.34

0.05 (-2.09%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add EQRX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#230 of 345

in industry

EQRX INC (EQRX) Price Targets From Analysts

Use the tables below to see what analysts covering EQRX INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-23 1 $5.6 $5.6 $5.6 $2.34 139.32%
2022-05-13 2 $5.6 $5.6 $5.6 $2.34 139.32%
2022-06-11 4 $8 $5.6 $6.8 $2.34 190.6%
2022-08-16 4 $8 $5.5 $6.366 $2.34 172.05%
2022-11-11 4 $5.5 $3.2 $4.566 $2.34 95.13%
2023-05-08 4 $5 $2.1 $3.55 $2.34 51.71%
2023-05-10 2 $3 $3 $3 $2.34 28.21%
NA 1 $NA $NA $NA $2.34 NA%

The Trend in the Analyst Price Target


Over the past 14 months, EQRX's average price target has gone down $2.6.

EQRX reports an average of 66.53% for its upside potential over the past 2 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-08 4 5 2.1 3.55 1.84 92.93%
2023-05-10 3 3 3.0 3.00 1.70 76.47%
2023-05-10 1 3 2.1 2.55 1.70 50%
2023-05-10 2 3 3.0 3.00 1.70 76.47%
2023-05-10 1 3 3.0 3.00 1.70 76.47%

EQRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.67 0 0 2 1 1 3

The Trend in the Broker Recommendations


EQRX's average broker recommendation rating worsened by 2.67 over the prior 14 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • EQRX has a greater average analyst price target than 47.15% of all US stocks.
  • In the context of all US stocks, EQRX INC's number of analysts covering the stock is higher than 110.71% of them.
  • In the context of Pharmaceutical Products stocks, EQRX INC's variance in analysts' estimates is lower than -126.28% of them.
  • In terms of how EQRX INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 828.98% of that group.

In the Pharmaceutical Products industry, ERAS, NUVL, and VTYX are the three stocks most similar to EQRX INC regarding the price target and analyst recommendation information presented here.

What is the outlook for EQRX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!